Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

China · Delayed Price · Currency is CNY

18.18

-0.81 (-4.27%)

At close: Jun 2, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Selling goods				227.45M	197.83M	66.30M	-
Selling goods Growth				14.97%	198.41%	-	-
Services				111.01M	35.38M	7.64M	3.15M
Services Growth				213.77%	362.87%	142.46%	-
Molecular Detection Products - Nucleic Acid Preservation Reagent				-	-	-	12.43M
Molecular Detection Products - Nucleic Acid Extraction and Purification Reagents				-	-	-	12.60M
Other				-	-	-	1.05M
Molecular Detection Products - Raw Enzymes and Detection Reagents				-	-	-	26.59M
Total				338.46M	233.21M	73.94M	55.83M
Total Growth				45.13%	215.41%	32.44%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China				290.69M	206.68M	72.82M	55.69M
China Growth				40.65%	183.83%	30.75%	-
Foreign				47.78M	26.53M	1.12M	136.30K
Foreign Growth				80.06%	2268.70%	721.85%	-
Total				338.46M	233.21M	73.94M	55.83M
Total Growth				45.13%	215.41%	32.44%	-

Source: S&P Global Market Intelligence.